(730 ILCS 166/25)
Sec. 25. Procedure.
(a) A screening and clinical needs assessment and risk assessment of the
defendant shall be performed as required by the court's policies and procedures prior to the defendant's admission into a drug court. The clinical needs assessment shall be conducted in accordance with the Department of Human Services substance use prevention and recovery rules under 77 Ill. Adm. Code 2060. The assessment shall include, but is not limited to, assessments of substance use and mental and behavioral health needs. The assessment shall be administered by individuals approved under the Department of Human Services substance use prevention and recovery rules for professional staff under 77 Ill. Adm. Code 2060 and used to inform any clinical treatment plans. Clinical treatment plans shall be developed in accordance with the Problem-Solving Court Standards and in part upon the known availability of treatment resources. Any risk assessment shall be performed using an assessment tool approved by the Administrative Office of the Illinois Courts and as required by the court's policies and procedures. An assessment need not be ordered if the
court finds a valid assessment related to the present charge pending against
the defendant has been completed within the previous 60 days.
(b) The judge shall inform the defendant that if the defendant fails to
meet the conditions of the drug court program, eligibility to participate in
the
program may be revoked and the defendant may be sentenced or the prosecution
continued as provided in
the
Unified Code of Corrections for the crime charged.
(c) The defendant shall execute a written agreement as to his or her
participation in the program and shall agree to all of the terms and conditions
of the program, including but not limited to the possibility of sanctions or
incarceration for failing to abide or comply with the terms of the program.
(d) In addition to any conditions authorized under the Pretrial Services
Act and Section 5-6-3 of the Unified Code of Corrections, the court may order
the participant to complete mental health counseling or substance use disorder treatment in an outpatient or residential treatment program and may order the participant to comply with physicians' recommendations regarding medications and all follow-up treatment for any mental health diagnosis made by the provider. Substance use disorder treatment programs must be licensed by the Department of Human Services in accordance with the Department of Human Services substance use prevention and recovery rules, or an equivalent standard in any other state where the treatment may take place, and use evidence-based treatment. When referring participants to mental health treatment programs, the court shall prioritize providers certified as community mental health or behavioral health centers if possible. The court shall consider the least restrictive treatment option when ordering mental health or substance use disorder treatment for participants and the results of clinical and risk assessments in accordance with the Problem-Solving Court Standards.
(e) The drug court program shall include a regimen of graduated
requirements, including fines,
fees, costs, restitution, individual and group
therapy, substance
analysis testing, close monitoring by the court, restitution, educational or vocational counseling as
appropriate, and other
requirements necessary to fulfill the drug court program. Program phases, therapeutic adjustments, incentives, and sanctions, including the use of jail sanctions, shall be administered in accordance with evidence-based practices and the Problem-Solving Court Standards. A participant's failure to pay program fines or fees shall not prevent the participant from advancing phases or successfully completing the program. If the participant needs treatment for an opioid use disorder or dependence, the court may not prohibit the participant from
receiving medication-assisted treatment under the care of
a physician licensed in this State to practice medicine in all
of its branches. Drug court participants may not be required to refrain from using medication-assisted treatment as a term or condition of successful completion of the drug court program.
(f) Recognizing that individuals struggling with mental health, substance use, and related co-occurring disorders have often experienced trauma, drug court programs may include specialized service programs specifically designed to address trauma. These specialized services may be offered to individuals admitted to the drug court program. Judicial circuits establishing these specialized programs shall partner with advocates, survivors, and service providers in the development of the programs. Trauma-informed services and programming shall be operated in accordance with evidence-based best practices as outlined by the Substance Abuse and Mental Health Service Administration's National Center for Trauma-Informed Care. (g) The court may establish a mentorship program that provides access and support to program participants by peer recovery coaches. Courts shall be responsible to administer the mentorship program with the support of mentors and local mental health and substance use disorder treatment organizations. (Source: P.A. 102-1041, eff. 6-2-22.)
|